GLP-1 receptor agonists: An example of the challenge for animal models to predict plaque instability/rupture and cardiovascular outcomes.

Ying, Ya-Lan; Chen, Yung-Chih; Jandeleit-Dahm, Karin; Peter, Karlheinz

Ying, Ya-Lan; Chen, Yung-Chih; Jandeleit-Dahm, Karin; Peter, Karlheinz.

Afiliação

Ying YL; Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne, Australia.
Chen YC; Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne, Australia.
Jandeleit-Dahm K; Department of Diabetes, Monash University, Melbourne, Australia.
Peter K; Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Medicine, Monash University, Melbourne, Australia. Electronic address: karlheinz.peter@baker.edu.au.

Atherosclerosis ; 265: 250-252, 2017 10.

Article em En | MEDLINE | ID: mdl-28870630

Assuntos

Sistema Cardiovascular; Placa Aterosclerótica; Animais; Fluspirileno; Receptor do Peptídeo Semelhante ao Glucagon 1; Modelos Animais; Coelhos

Palavras-chave

Animal models; Atherosclerosis; GLP-1 receptor agonists; Plaque instability; Plaque rupture; Type II diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Cardiovascular / Placa Aterosclerótica Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Cardiovascular / Placa Aterosclerótica Idioma: En Ano de publicação: 2017 Tipo de documento: Article